Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study.
Sheila M GrecianStela McLachlanJonathan Andrew FallowfieldPatrick K A KearnsPeter C HayesNeil I GuhaJoanne R MorlingStephen GlancyRachel M WilliamsonRebecca M ReynoldsBrian M FrierNicola N ZammittJackie F PriceMark W J StrachanPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
In a cohort with a moderately low incidence of cirrhosis/HCC, existing risk scores did not reliably identify participants at high risk. Better prediction models for cirrhosis/HCC in people with Type 2 diabetes are required.